Laurel Wealth Advisors (California)’s Neurocrine Biosciences NBIX Stock Holding History

Laurel Wealth Advisors (California)’s Portfolio NBIX Stock Details NBIX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$205K	Sell
2022 Q3	$205K	Sell
2022 Q2	$204K	Sell
2022 Q1	$262K	Sell
2021 Q4	$244K	Buy